Caption Management, LLC Apellis Pharmaceuticals, Inc. Put Options Transaction History

Caption Management, LLC

$5.74 Billion
Q3 2024

Put Options

15 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$28.84 - $41.15 $3 Million - $4.28 Million	-103,900 Reduced 63.39%	60,000 $1.73 Million
Q2 2024 Aug 14, 2024	BUY	$38.07 - $59.71 $3.96 Million - $6.2 Million	103,900 Added 173.17%	163,900 $6.29 Million
Q1 2024 May 15, 2024	SELL	$55.39 - $72.47 $9.93 Million - $13 Million	-179,300 Reduced 74.93%	60,000 $3.53 Million
Q4 2023 Feb 14, 2024	SELL	$37.14 - $64.82 $583,098 - $1.02 Million	-15,700 Reduced 6.16%	239,300 $14.3 Million
Q3 2023 Nov 14, 2023	BUY	$23.65 - $89.22 $2.96 Million - $11.2 Million	125,000 Added 96.15%	255,000 $9.7 Million
Q2 2023 Aug 14, 2023	SELL	$76.68 - $93.31 $10.8 Million - $13.1 Million	-140,500 Reduced 51.94%	130,000 $11.8 Million
Q1 2023 May 15, 2023	BUY	$46.59 - $66.96 $9.34 Million - $13.4 Million	200,500 Added 286.43%	270,500 $17.8 Million
Q4 2022 Feb 14, 2023	BUY	$43.24 - $61.04 $3.03 Million - $4.27 Million	70,000 New	70,000 $3.62 Million
Q2 2022 Aug 15, 2022	SELL	$35.07 - $59.21 $22.7 Million - $38.4 Million	-648,700 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$35.46 - $54.12 $15.2 Million - $23.2 Million	428,700 Added 194.86%	648,700 $33 Million
Q4 2021 Feb 11, 2022	SELL	$30.74 - $49.16 $11.2 Million - $18 Million	-365,300 Reduced 62.41%	220,000 $10.4 Million
Q3 2021 Nov 12, 2021	BUY	$31.4 - $69.84 $12.6 Million - $28 Million	400,300 Added 216.38%	585,300 $19.3 Million
Q2 2021 Aug 16, 2021	BUY	$40.9 - $64.9 $7.57 Million - $12 Million	185,000 New	185,000 $11.7 Million
Q4 2020 Feb 16, 2021	SELL	$30.79 - $57.2 $923,700 - $1.72 Million	-30,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$25.89 - $33.65 $776,700 - $1.01 Million	30,000 New	30,000 $904,000

Others Institutions Holding APLS

# of Institutions

308

Shares Held

115M

Call Options Held

3.85M

Put Options Held

1.09M

Wellington Management Group LLP Boston, MA

15.6M
Shares

$516 Million
0.08% of portfolio
Eco R1 Capital, LLC San Francisco, CA

11.9M
Shares

$394 Million
14.88% of portfolio
Avoro Capital Advisors LLC New York, NY

11.1M
Shares

$368 Million
4.82% of portfolio
Vanguard Group Inc Valley Forge, PA

9.82M
Shares

$325 Million
0.01% of portfolio
Black Rock Inc. New York, NY

5.8M
Shares

$192 Million
0.01% of portfolio

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.64B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Account